<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02937805</url>
  </required_header>
  <id_info>
    <org_study_id>MCMM</org_study_id>
    <nct_id>NCT02937805</nct_id>
  </id_info>
  <brief_title>Effects of a Moisturizing Cream on Vaginal and Vulvar Mucous Membranes</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Petra Larmo</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Turun Gynekologikeskus Oy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tekes - The Finnish Funding Agency for Technology and Innovation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aromtech Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vulvovaginal atrophy is a common problem associated with decreased levels of estrogen.
      Typical symptoms include feelings of dryness and uncomfort of the mucous membranes of
      intimate area. The objective of this study is to investigate the effects of a non-hormonal
      moisturizing cream on symptoms and signs of vulvovaginal atrophy and dryness.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in symptoms of vaginal health index: scores of vaginal mucosa elasticity, fluid, pH, epithelial integrity, moisture</measure>
    <time_frame>Baseline, 5 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in vaginal and vulvar pH</measure>
    <time_frame>Baseline, 5 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in signs of vaginal and vulvar dryness: VAS evaluation by the study gynecologist</measure>
    <time_frame>Baseline, 5 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in signs of vaginal and vulvar mucosal integrity: VAS evaluation by the study gynecologist</measure>
    <time_frame>Baseline, 5 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in signs of vaginal and vulvar inflammation and irritation: VAS evaluation by the study gynecologist</measure>
    <time_frame>Baseline, 5 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in symptoms of vaginal and vulvar atrophy and dryness: symptom questionnaires; scoring from 0 to 3 dryness, burning, itching; VAS evaluation of mucosal dryness, irritation, soreness, pain during exercise, pain during intercourse</measure>
    <time_frame>Baseline, 5 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in symptoms of vaginal and vulvar atrophy and dryness: symptom logbooks; daily scoring from 0 to 3 dryness, burning, itching, pain, soreness, symptoms during intercourse</measure>
    <time_frame>From baseline to 5 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">225</enrollment>
  <condition>Vaginal Dryness</condition>
  <condition>Vaginal Atrophy</condition>
  <condition>Vulvar Dryness</condition>
  <condition>Vulvar Atrophy</condition>
  <arm_group>
    <arm_group_label>Moisturizing vaginal and vulvar sea buckthorn oil cream</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Moisturizing non-hormonal vaginal and vulvar cream containing sea buckthorn oil as active ingredient (medical device product in development). Administered twice or once per day for 5 weeks. Post-menopausal women n= 55 + 45. Pre-menopausal women n=15</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moisturizing vaginal and vulvar cream</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Moisturizing non-hormonal vaginal and vulvar cream (commercial medical device cream already on the market, not containing sea buckthorn oil). Administered once - twice per day for 5 weeks. Postmenopausal women n=55</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No moisturizing vaginal and vulvar cream for 5 weeks. Postmenopausal women n=55</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Moisturizing vaginal and vulvar sea buckthorn oil cream</intervention_name>
    <arm_group_label>Moisturizing vaginal and vulvar sea buckthorn oil cream</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Moisturizing vaginal and vulvar cream</intervention_name>
    <arm_group_label>Moisturizing vaginal and vulvar cream</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Symptoms of vaginal dryness, burning or itching

          -  Symptom severity at least moderate

        Exclusion Criteria:

          -  Systemic hormonal replacement therapy during the last 12 months

          -  Local hormonal replacement therapy during the last 4 weeks

          -  Known allergy to ingredients of the study creams

          -  Pregnancy

          -  Breast-feeding
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Risto Erkkola, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Turun Gynekologikeskus</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Turun Gynekologikeskus</name>
      <address>
        <city>Turku</city>
        <zip>20100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 11, 2016</study_first_submitted>
  <study_first_submitted_qc>October 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 2016</study_first_posted>
  <last_update_submitted>June 19, 2017</last_update_submitted>
  <last_update_submitted_qc>June 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Aromtech Ltd.</investigator_affiliation>
    <investigator_full_name>Petra Larmo</investigator_full_name>
    <investigator_title>R&amp;D Manager</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

